| Microfluidic organoids-on-a-chip: Quantum leap in cancer research F Duzagac, G Saorin, L Memeo, V Canzonieri, F Rizzolio Cancers 13 (4), 737, 2021 | 63 | 2021 |
| Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol BC Soner, H Aktug, E Acikgoz, F Duzagac, U Guven, S Ayla, C Cal, ... International journal of molecular medicine 34 (5), 1249-1256, 2014 | 54 | 2014 |
| Self-therapeutic nanomaterials for cancer therapy: a review M Adeel, F Duzagac, V Canzonieri, F Rizzolio ACS Applied Nano Materials 3 (6), 4962-4971, 2020 | 48 | 2020 |
| Enhanced G2/M arrest, caspase related apoptosis and reduced E-cadherin dependent intercellular adhesion by trabectedin in prostate cancer stem cells E Acikgoz, U Guven, F Duzagac, R Uslu, M Kara, BC Soner, G Oktem PLoS One 10 (10), e0141090, 2015 | 37 | 2015 |
| JAK/STAT pathway interacts with intercellular cell adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM) while prostate cancer stem cells form tumor spheroids F Duzagac, S Inan, F Ela Simsek, E Acikgoz, U Guven, SA Khan, ... J buon 20 (5), 1250-1257, 2015 | 29 | 2015 |
| Cancer extracellular vesicles: next-generation diagnostic and drug delivery nanotools S Palazzolo, L Memeo, M Hadla, F Duzagac, A Steffan, T Perin, ... Cancers 12 (11), 3165, 2020 | 25 | 2020 |
| Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44+/CD24‑breast cancer stem cells A Erol, E Acikgoz, U Guven, F Duzagac, A Turkkani, N Colcimen, G Oktem Oncology Letters 14 (6), 6433-6440, 2017 | 13 | 2017 |
| Repression of the Notch pathway prevents liver damage in streptozotocin-induced diabetic mice E Acikgoz, H Aktug, G Yigitturk, K Demir, U Guven, F Duzagac, F Oltulu, ... Folia histochemica et cytobiologica 55 (3), 140-148, 2017 | 9 | 2017 |
| “Double hit” strategy: Removal of sialic acid from the dendritic cell surface and loading with CD44+/CD24-/low cell lysate inhibits tumor growth and metastasis by targeting … E Acikgoz, F Duzagac, U Guven, G Yigitturk, T Kose, G Oktem International Immunopharmacology 107, 108684, 2022 | 8 | 2022 |
| New psychoactive substance 5-MeO-MiPT in vivo acute toxicity and hystotoxicological study YA Altuncı, M Aydoğdu, E Açıkgöz, Ü Güven, F Düzağaç, A Atasoy, ... Balkan Medical Journal 38 (1), 34, 2021 | 8 | 2021 |
| Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome AM Bolivar, F Duzagac, KM Sinha, E Vilar Molecular Aspects of Medicine 93, 101204, 2023 | 1 | 2023 |
| Inhibition of histone methyltransferase EZH2 for immune-interception of colorectal cancer in Lynch syndrome F Duzagac, CM Bowen, L Reyes-Uribe, M Zaheer, J Thompson, N Deng, ... Cancer Research 84 (6_Supplement), 7552-7552, 2024 | | 2024 |
| Microfluidic production of amiodarone loaded nanoparticles and application in drug repositioning in ovarian cancer A Saorin, G Saorin, F Duzagac, P Parisse, N Cao, G Corona, ... Scientific Reports 14 (1), 6280, 2024 | | 2024 |
| Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention AM Bolivar, F Duzagac, N Deng, L Reyes-Uribe, K Chang, W Wu, ... Gastroenterology, 2024 | | 2024 |
| Abstract C124: Assessment of the anticancer potential of a natural compound euphol in colorectal cancer from in vitro and in vivo mouse models ALV Alves, AC Martin, KM Sinha, VAO Silva, RJ da Silva-Oliveira, ... Molecular Cancer Therapeutics 22 (12_Supplement), C124-C124, 2023 | | 2023 |
| Expression of the Low-density Lipoprotein Receptor (LDLR) Gene Family in CD133+/CD44+ Prostate Cancer Stem Cells BC Soner, E Açıkgöz, F Duzagac, C Parlayan Journal of Basic and Clinical Health Sciences 7 (1), 410-417, 2023 | | 2023 |
| 28 Identification and functional validation of neoantigens-specific T-cell receptors in lynch syndrome F Duzagac, K Sinha, A Bolivar, N Deng, LR Uribe, A Reuben, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 36 Analysis of T-cell receptor sequences identifies signatures associated with neoantigen exposure in peripheral blood of lynch syndrome patients A Bolivar, E Vilar-Sanchez, K Sinha, LR Uribe, N Deng, F Duzagac, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Epigenetic intervention in the prevention of Lynch Syndrome Colorectal Cancer LR Uribe, CM Bowen, K Evans, H Wu, F Duzagac, K Sinha, E Vilar Cancer Research 82 (12_Supplement), 721-721, 2022 | | 2022 |
| Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research. Cancers 2021, 13, 737 F Duzagac, G Saorin, L Memeo, V Canzonieri, F Rizzolio s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
